| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 80.84B | 87.86B | 80.18B | 73.03B | 67.66B | 64.99B |
| Gross Profit | 34.34B | 37.85B | 34.95B | 31.62B | 29.09B | 25.91B |
| EBITDA | 28.06B | 34.13B | 28.66B | 27.49B | 22.39B | 21.05B |
| Net Income | 13.77B | 15.85B | 14.36B | 13.59B | 10.49B | 8.87B |
Balance Sheet | ||||||
| Total Assets | 192.74B | 260.19B | 184.91B | 172.80B | 163.62B | 158.28B |
| Cash, Cash Equivalents and Short-Term Investments | 55.47B | 55.79B | 53.66B | 52.90B | 54.81B | 61.06B |
| Total Debt | 74.63B | 115.63B | 66.53B | 61.20B | 66.78B | 79.81B |
| Total Liabilities | 97.32B | 146.12B | 90.22B | 84.78B | 84.64B | 98.21B |
| Stockholders Equity | 94.35B | 109.83B | 94.27B | 87.56B | 78.49B | 59.74B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 7.75B | 6.67B | 8.55B | 3.33B | 386.00M |
| Operating Cash Flow | 0.00 | 25.46B | 23.02B | 21.67B | 16.27B | 18.05B |
| Investing Cash Flow | 0.00 | -65.11B | -18.96B | -15.56B | -12.30B | -16.45B |
| Financing Cash Flow | 0.00 | 41.43B | -3.54B | -7.64B | -8.97B | -3.17B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥185.28B | 19.98 | 11.00% | 2.20% | 6.75% | -0.17% | |
73 Outperform | ¥25.92B | 13.62 | ― | 2.62% | -14.20% | 231.20% | |
72 Outperform | ¥376.10B | 23.64 | ― | 1.30% | 9.57% | 9.73% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
57 Neutral | ¥4.98B | 9.29 | ― | 1.80% | 4.07% | -20.12% | |
56 Neutral | ¥2.14B | 89.69 | ― | 1.93% | -22.86% | -86.49% | |
49 Neutral | ¥5.93B | 20.87 | ― | 1.36% | -4.59% | -14.60% |